-
Mashup Score: 2The Endocrine community joins forces on European Hormone Day to raise - 12 month(s) ago
PRESS RELEASE Credit: European Society of Endocrinology PRESS RELEASE EMBARGOED TO 15 MAY 2023 Contact: Victoria Withy Head of Marketing, Communications and Membership E: vi
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0
Philadelphia, February 8, 2023 – American Indians and Alaska Natives (AI/AN) have traditional food and nutrition practices that support holistic health. However, these traditional practices have b
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 118
TAMPA, Fla. (Sept. 20, 2022) – About 40 million adults in the United States regularly take statins to lower their cholesterol levels and reduce their risk of heart disease and stroke, according to A
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Genetic score detects those at risk for sudden cardiac death - 2 year(s) ago
Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that
Categories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
HOUSTON ― The highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses in patients with RET fusion-positive cancers regardless of tumor type, a
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
HOUSTON ― The highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses in patients with RET fusion-positive cancers regardless of tumor type, a
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Hypertension is a prevalent condition among the least educated and poorest people in low- and middle-income countries (LMICs), despite often presumed low rates of common risk factors like sedentary
Categories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
HOUSTON ― The highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses in patients with RET fusion-positive cancers regardless of tumor type, a
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
In an analysis of medical information of more than 6,000 American adults with a history of cardiovascular disease (CVD), researchers at Johns Hopkins Medicine conclude that CVD risk “profiles” in sec
Categories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Gut microbes differ in men with prostate cancer - 2 year(s) ago
Researchers have found a significant difference in the gut microbiota of men with prostate cancer, compared with those who have benign biopsies. The study is presented at the European Association of
Categories: Latest Headlines, UrologyTweet
Thank you to everyone who joined us in celebrating European Hormone Day yesterday! Together we can be a force for good, ultimately improving outcomes for endocrine patients. #BecauseHormonesMatter #ECE2023 https://t.co/MKkIWT9wng https://t.co/L2UmHScPLb